Samenvatting: Incyte licht nieuwe gegevens van tafasitamab Fase 3 toe tijdens de 2026 ASCO (American Society of Clinical Oncology) Annual Meeting
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in